An update on antibody-based immunotherapies for Clostridium difficile infection

Clostridium difficile continues to be one of the most prevalent hospital-acquired bacterial infections in the developed world, despite the recent introduction of a novel and effective antibiotic agent (fidaxomicin). Alternative approaches under investigation to combat the anaerobic Gram-positive bac...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussack, Greg, Tanha, Jamshid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975149/
https://www.ncbi.nlm.nih.gov/pubmed/27536153
http://dx.doi.org/10.2147/CEG.S84017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975149/
https://www.ncbi.nlm.nih.gov/pubmed/27536153
http://dx.doi.org/10.2147/CEG.S84017

Ejemplares similares